These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30350263)

  • 1. Downregulation of IGF1R Expression Inhibits Growth and Enhances Cisplatin Sensitivity of Head and Neck Squamous Cell Carcinoma Cells In Vitro.
    Khalil A; Jameson MJ
    Horm Cancer; 2019 Feb; 10(1):11-23. PubMed ID: 30350263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the insulin-like growth factor-1 receptor induces resistance to epidermal growth factor receptor antagonism in head and neck squamous carcinoma cells.
    Jameson MJ; Beckler AD; Taniguchi LE; Allak A; Vanwagner LB; Lee NG; Thomsen WC; Hubbard MA; Thomas CY
    Mol Cancer Ther; 2011 Nov; 10(11):2124-34. PubMed ID: 21878657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRAS40 Phosphorylation Correlates with Insulin-Like Growth Factor-1 Receptor-Induced Resistance to Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells.
    Dougherty MI; Lehman CE; Spencer A; Mendez RE; David AP; Taniguchi LE; Wulfkuhle J; Petricoin EF; Gioeli D; Jameson MJ
    Mol Cancer Res; 2020 Sep; 18(9):1392-1401. PubMed ID: 32467173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway.
    Yang Z; Liao J; Carter-Cooper BA; Lapidus RG; Cullen KJ; Dan H
    BMC Cancer; 2019 May; 19(1):485. PubMed ID: 31118072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR4 enhances cisplatin resistance of human tongue squamous cell carcinoma.
    Zhuang XM; Zhou B
    J Oral Pathol Med; 2019 Feb; 48(2):122-128. PubMed ID: 30554431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of IGF-1R expression inhibits growth and enhances chemosensitivity of endometrial carcinoma in vitro.
    Shu S; Yang Y; Li X; Li T; Zhang Y; Xu C; Liang C; Wang X
    Mol Cell Biochem; 2011 Jul; 353(1-2):225-33. PubMed ID: 21442237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effect of insulin-like growth factor-1 receptor inhibition in head and neck squamous cell carcinoma.
    Lehman CE; Khalil AA; Axelrod MJ; Dougherty MI; Schoeff SS; Taniguchi LE; Mendez RE; David AP; McGarey PO; Hubbard MA; Donaldson L; Frierson HF; Stelow EB; Bekiranov S; Wulfkuhle JD; Petricoin EF; Gioeli DG; Jameson MJ
    Laryngoscope; 2020 Jun; 130(6):1470-1478. PubMed ID: 31433065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of GLUT1 on the survival of head and neck squamous cell carcinoma.
    Li S; Yang X; Wang P; Ran X
    Cell Physiol Biochem; 2013; 32(3):624-34. PubMed ID: 24022001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zerumbone acts as a radiosensitizer in head and neck squamous cell carcinoma.
    Schnoell J; Stanisz I; Jank BJ; Stanek V; Schmid R; Brunner M; Heiduschka G; Kotowski U
    Invest New Drugs; 2022 Apr; 40(2):224-231. PubMed ID: 34613571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of insulin-like growth factor 1 receptor enhances chemosensitivity to cisplatin in human lung adenocarcinoma A549 cells.
    Dong A; Kong M; Ma Z; Qian J; Cheng H; Xu X
    Acta Biochim Biophys Sin (Shanghai); 2008 Jun; 40(6):497-504. PubMed ID: 18535748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins.
    Tanaka N; Patel AA; Wang J; Frederick MJ; Kalu NN; Zhao M; Fitzgerald AL; Xie TX; Silver NL; Caulin C; Zhou G; Skinner HD; Johnson FM; Myers JN; Osman AA
    Clin Cancer Res; 2015 Nov; 21(21):4831-44. PubMed ID: 26124202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinatorial Effects of Curcumin with an Anti-Neoplastic Agent on Head and Neck Squamous Cell Carcinoma Through the Regulation of EGFR-ERK1/2 and Apoptotic Signaling Pathways.
    Sivanantham B; Sethuraman S; Krishnan UM
    ACS Comb Sci; 2016 Jan; 18(1):22-35. PubMed ID: 26505786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of high-mobility group box 2 (HMGB2) modulates cisplatin and 5-fluorouracil sensitivity in head and neck squamous cell carcinoma.
    Syed N; Chavan S; Sahasrabuddhe NA; Renuse S; Sathe G; Nanjappa V; Radhakrishnan A; Raja R; Pinto SM; Srinivasan A; Prasad TS; Srikumar K; Gowda H; Santosh V; Sidransky D; Califano JA; Pandey A; Chatterjee A
    Proteomics; 2015 Jan; 15(2-3):383-93. PubMed ID: 25327479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of glucose transporter 1 (GLUT1) chemosensitized head and neck cancer cells to cisplatin.
    Wang YD; Li SJ; Liao JX
    Technol Cancer Res Treat; 2013 Dec; 12(6):525-35. PubMed ID: 23617290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma.
    Mohan S; Vander Broek R; Shah S; Eytan DF; Pierce ML; Carlson SG; Coupar JF; Zhang J; Cheng H; Chen Z; Van Waes C
    Clin Cancer Res; 2015 Sep; 21(17):3946-56. PubMed ID: 25977343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine Kinase Inhibitors and Everolimus Reduce IGF1R Expression in HPV16-positive and -negative Squamous Cell Carcinoma.
    Kramer B; Schell A; Aderhold C; Huber L; Mueller CE; Rotter N; Birk R
    Anticancer Res; 2020 Jul; 40(7):3847-3855. PubMed ID: 32620624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance.
    Selfe J; Goddard NC; McIntyre A; Taylor KR; Renshaw J; Popov SD; Thway K; Summersgill B; Huddart RA; Gilbert DC; Shipley JM
    J Pathol; 2018 Feb; 244(2):242-253. PubMed ID: 29160922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting acid ceramidase sensitises head and neck cancer to cisplatin.
    Roh JL; Park JY; Kim EH; Jang HJ
    Eur J Cancer; 2016 Jan; 52():163-72. PubMed ID: 26687835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis and sensitization of head and neck squamous carcinoma cells to cisplatin by targeting survivin gene expression.
    Khan Z; Tiwari RP; Khan N; Prasad GB; Bisen PS
    Curr Gene Ther; 2012 Dec; 12(6):444-53. PubMed ID: 22974420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The EGFR Inhibitor Gefitinib Enhanced the Response of Human Oral Squamous Cell Carcinoma to Cisplatin In Vitro.
    Khalil A; Jameson MJ
    Drugs R D; 2017 Dec; 17(4):545-555. PubMed ID: 28828595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.